subscribeSubscribe
Cancer scientist failed to disclose industry payments — does that matter?

Cancer scientist failed to disclose industry payments — does that matter?
John Carroll ENDPTS
10 Sep 2018
Share Share
Novartis considers filings for PI3K drug in breast cancer

Novartis considers filings for PI3K drug in breast cancer
Phil Taylor PMLIVE
24 Aug 2018
Share Share
Novartis succeeds where Roche failed with PI3K breast cancer drug

Novartis succeeds where Roche failed with PI3K breast cancer drug
Piotr Wnuk PHARMAPHORUM
23 Aug 2018
Share Share
Novartis just boasted of a big PhIII PI3K success

Novartis just boasted of a big PhIII PI3K success
John Carroll ENDPTS
23 Aug 2018
Share Share
Novartis trial win lifts profile of new breast cancer drug

Novartis trial win lifts profile of new breast cancer drug
John Miller REUTERS
23 Aug 2018
Share Share
Novartis hands off buparlisib to China`s Adlai Noryte

Novartis hands off buparlisib to China`s Adlai Noryte
Amirah Al Idrus FIERCE BIOTECH
12 Jul 2018
Share Share
Novartis punts a late-stage PI3K drug to China’s biotechs

Novartis punts a late-stage PI3K drug to China’s biotechs
John Carroll ENDPTS
12 Jul 2018
Share Share
Two Roche Cancer Drugs Get Disappointing Results

Two Roche Cancer Drugs Get Disappointing Results
Don McCormick BIOSPACE
04 Jun 2018
Share Share
ASCO: Roche punts taselisib after weak data, severe side effects

ASCO: Roche punts taselisib after weak data, severe side effects
Ben Adams FIERCE BIOTECH
04 Jun 2018
Share Share
Roche drugs show limited benefit in lung, breast cancer trials

Roche drugs show limited benefit in lung, breast cancer trials
Deena Beasley REUTERS
04 Jun 2018
Share Share